Panel Discussion: Translational Considerations for 3D Printed Biomaterial-Based Constructs

Timeslot: Friday, April 5, 2019 - 1:45pm to 3:45pm
Track: Industry
Room: Yakima 2


The adoption of 3D printing, bioprinting, and other advanced techniques are increasingly used in new product development. In addition to advantages they may offer, these technologies have their own specific properties and limitations. While many of these processes use the same synthetic and biologic materials already used in a variety of marketed products, process-based risks must be reasonably determined and reduced to a safe level. There are notable examples of 3D printed products both in the United States and in other countries with early adoption mainly in the creation of surgical guides and models. Other products include custom tracheal implants, PEEK craniofacial plates, orthopedic implants, and the like. The ultimate promise for many is the potential to build engineered tissue structures, up to full organ replacements, to advance biomedical products well beyond the current limits. This session comprises a two-part panel discussion focused on various translational considerations including (1) advancing technology out of the lab, and (2) translating technologies into products for broad clinical use.


Abstracts will be available for download on April 3, 2019.

  • 1:45 PM 417. Invited Speaker

  • 2:15 PM 418. Invited Speaker

  • 2:45 PM 419. Invited Speaker

  • 3:15 PM 420. Invited Speaker